Mounjaro (Tirzepatide) Shortage Update: What Patients Need to Know in 2025

Mounjaro (tirzepatide) has experienced significant supply shortages since its rapid rise in popularity following FDA approval in 2022. While the FDA removed tirzepatide from its official drug shortage database in late 2024, real-world availability remains inconsistent — and patients across the country are still running into empty pharmacy shelves. Here's what's actually happening, why it keeps occurring, and what you can do to protect your treatment.

---

A Quick Recap: Mounjaro's Shortage History

Mounjaro hit the US market in May 2022 as the first FDA-approved GIP/GLP-1 receptor agonist — a new class of injectable medication for type 2 diabetes. It works by mimicking two gut hormones at once (GIP and GLP-1), making it unusually effective at lowering blood sugar and, as many patients and doctors quickly noticed, promoting significant weight loss.

That last part changed everything.

Demand exploded. Physicians began prescribing Mounjaro off-label for obesity while its manufacturer, Eli Lilly, scrambled to keep up. By 2023, tirzepatide had landed on the FDA's official drug shortage list — meaning supply was genuinely unable to meet medical demand across the country. Pharmacies were rationing doses. Patients were driving hours to find their medication. Some were skipping injections entirely.

Eli Lilly invested heavily in expanding manufacturing capacity, and the FDA formally removed tirzepatide from its shortage list in December 2024. That was a meaningful step forward. But "removed from the shortage list" doesn't always mean "easy to find at your local pharmacy" — and many patients are still experiencing gaps.

---

Why Does Mounjaro Keep Running Short?

Understanding why shortages happen can help you plan better and feel less like you're doing something wrong when you can't find your medication. You're not. This is a supply chain problem, not a you problem.

Demand Far Outpaced Supply

When a drug becomes unexpectedly popular this fast, no manufacturer — no matter how large — can respond overnight. Producing injectable biologics like tirzepatide requires specialized facilities, precise manufacturing processes, and years of regulatory validation. Eli Lilly couldn't simply flip a switch and triple output.

The Weight Loss Effect

Mounjaro was originally approved for type 2 diabetes. But word spread quickly about its weight loss results, and off-label prescribing surged. This added an entirely new patient population to existing demand — without a corresponding increase in supply. Zepbound, Eli Lilly's tirzepatide product specifically approved for chronic weight management, launched in late 2023 to help separate these patient pools, but both products draw from overlapping manufacturing pipelines.

Dose-Specific Shortages Are Still Common

Even when the overall drug is "available," specific doses are often not. Mounjaro comes in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Patients typically start at 2.5 mg and titrate up over time. Shortages tend to hit the mid-range doses hardest — the 5 mg and 7.5 mg strengths — because that's where most patients end up after their starting period. Your dose may be unavailable even when other strengths are in stock nearby.

Distribution Is Uneven

Pharmacy chains and independent pharmacies don't all receive the same allocations. A CVS in one ZIP code might have stock while a Walgreens three miles away has been out for two weeks. This uneven distribution makes the shortage feel worse than it might look on paper — and it's why calling around (or having someone do it for you) has become a frustrating but necessary part of managing this prescription.

---

Current FDA Shortage Status

As of late 2024 and into 2025, tirzepatide (the active ingredient in both Mounjaro and Zepbound) is no longer listed as an official shortage on the FDA Drug Shortages database. This reflects Eli Lilly's expanded manufacturing and improved supply chains.

However, the FDA's designation is a national-level assessment. It doesn't guarantee your specific dose will be on the shelf at your specific pharmacy on the day your prescription is due. Localized shortages, dose-specific gaps, and regional distribution imbalances continue to affect patients in real, daily ways.

The FDA also moved to crack down on compounding pharmacies that had been producing tirzepatide copies during the shortage period. With the official shortage resolved, the agency has restricted compounders from continuing to produce these versions — which means patients who had been relying on compounded tirzepatide may need to transition back to branded Mounjaro or Zepbound.

---

What Should You Do If You Can't Find Mounjaro?

1. Don't Skip Doses Without Talking to Your Doctor First

Missing doses of Mounjaro isn't just inconvenient — it can affect your blood sugar control (if you're using it for diabetes) and may cause side effects when you restart. Always loop in your doctor before making any changes, including skipping a week.

2. Check Multiple Pharmacies

This sounds obvious, but it matters. Availability varies enormously from one location to the next — sometimes within the same neighborhood. Don't assume your usual pharmacy's answer is the final answer.

3. Ask About Your Specific Dose

When you or someone calls on your behalf, make sure to ask about your exact strength. A pharmacy might confirm they have Mounjaro in stock but not have your particular dose.

4. Ask Your Doctor About a Temporary Dose Hold

In some cases, your doctor may recommend pausing at your current dose rather than titrating up if supply is limited for the next strength. This is a medically reasonable approach that keeps you on therapy while you locate the right dose.

5. Explore Whether Zepbound Is Available

Zepbound is the same molecule (tirzepatide) approved for weight management. If you're using Mounjaro off-label for obesity and your doctor is on board, Zepbound may be easier to find in your area. Insurance coverage differs between the two, so check with your plan first.

6. Consider Manufacturer Support Programs

Eli Lilly offers savings programs for eligible commercially insured patients. These don't solve the availability problem, but they can reduce financial stress while you're navigating the search.

For a deeper look at what makes this drug so difficult to locate, see why is Mounjaro so hard to find.

---

Working With Your Doctor on Alternatives

If Mounjaro genuinely isn't available and a gap in treatment isn't safe, your doctor has options. The GLP-1 medication landscape has expanded significantly, and there are other approved therapies worth discussing.

Semaglutide-based medications (Ozempic for diabetes, Wegovy for weight management) work through a similar but not identical mechanism. They're not interchangeable with Mounjaro without medical guidance, but for some patients, a temporary switch makes sense. Your doctor will weigh your history, how well your current therapy is working, and what your insurance will cover.

Other diabetes medications — SGLT-2 inhibitors, for example — may also be appropriate depending on your clinical picture.

The key word here is your doctor. These aren't decisions to make on your own or based on what's cheapest or most available. A quick phone or portal message to your care team goes a long way.

For a full breakdown of alternatives, see alternatives to Mounjaro.

---

When Will the Mounjaro Shortage Fully Resolve?

The honest answer: it's complicated.

Eli Lilly has made substantial progress. New manufacturing capacity has come online, and the FDA's removal of tirzepatide from the official shortage list reflects genuine improvement. For most doses in most parts of the country, supply is better than it was in 2023.

That said, demand continues to grow as more patients are diagnosed with type 2 diabetes and obesity — two conditions affecting tens of millions of Americans. As long as demand growth tracks closely with supply increases, localized shortages and dose-specific gaps are likely to remain a periodic reality, not just a memory.

The introduction of Zepbound has helped separate the diabetes and weight management patient populations to some degree, and additional manufacturing expansion by Eli Lilly is ongoing.

The practical takeaway: things are getting better, but you shouldn't assume availability will be consistent just because the national shortage is "over." Staying proactive — keeping your prescription current, planning ahead of your refill date, and knowing where to turn when a gap hits — is still the smart approach.

---

How FindUrMeds Helps During a Mounjaro Shortage

Calling pharmacies when you're already stressed about a medication gap is exhausting. Most people give up after three or four calls. That's exactly the problem FindUrMeds was built to solve.

When you submit a request, our team contacts pharmacies across our network of 15,000+ locations — including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club — to find your specific medication and dose in stock near you. We do the calling so you don't have to.

Most patients hear back within 24–48 hours. We have a 92% success rate and are trusted by more than 200 healthcare providers across the country.

During the height of the Mounjaro shortage, FindUrMeds helped hundreds of patients bridge supply gaps without missing doses or abandoning their treatment plans. That kind of continuity matters — especially for a medication that works by staying consistently in your system.

For a step-by-step guide on locating Mounjaro near you, see how to find Mounjaro in stock near you.

---

The Bottom Line

Mounjaro has come a long way from the darkest days of its 2023 shortage. The FDA's removal of tirzepatide from the shortage list is genuinely good news. But real-world availability is still inconsistent, dose-specific gaps are common, and patients continue to face real frustration when their refill date arrives and their pharmacy comes up empty.

Your best defense is staying ahead of your refill, communicating with your doctor before missing a dose, and knowing that help is available when you need it.

You shouldn't have to manage a supply chain problem on top of managing your health.

---

Need help finding Mounjaro in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Mounjaro Near You →

---

Frequently Asked Questions

Is Mounjaro still on the FDA shortage list?

As of late 2024, tirzepatide (the active ingredient in Mounjaro) was removed from the FDA's official drug shortage database, reflecting improved supply from Eli Lilly. However, localized shortages and dose-specific gaps continue to affect many patients. The national designation doesn't guarantee availability at your local pharmacy.

What should I do if my pharmacy is out of my Mounjaro dose?

Don't skip your dose without speaking to your doctor first. Contact your care team, ask your pharmacy to check with their wholesaler, and consider having someone search across multiple pharmacy locations on your behalf. FindUrMeds can do this search for you across 15,000+ pharmacies nationwide.

Can I switch to Zepbound if I can't find Mounjaro?

Zepbound contains the same active ingredient (tirzepatide) but is approved specifically for chronic weight management rather than type 2 diabetes. Whether switching makes sense depends on your diagnosis, your prescription, and your insurance coverage. Talk to your doctor before making any changes — this isn't a self-switch situation.

Why is my specific Mounjaro dose so hard to find when other doses are available?

Shortages often hit specific doses harder than others. Mid-range doses like 5 mg and 7.5 mg tend to see the most demand because many patients are in that phase of their titration. Pharmacies receive allocations unevenly, so one location may have your dose while another nearby does not. Searching across multiple pharmacies for your exact strength is often necessary.

---

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →